SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-15-007187
Filing Date
2015-10-02
Accepted
2015-10-02 20:02:25
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 VALENCE/CPXX p6844658.html 4  
1 VALENCE/CPXX p6844658.xml 4 12803
  Complete submission text file 0000919574-15-007187.txt   15307
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Issuer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VALENCE LIFE SCIENCES LLC 500 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address VALENCE LIFE SCIENCES LLC 500 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-891-1100
Valence Life Sciences GP II LLC (Reporting) CIK: 0001576115 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 151141896

Mailing Address VALENCE LIFE SCIENCES LLC 500 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address
Roberts Eric W (Reporting) CIK: 0001576244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 151141894

Mailing Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE, 9TH FLOOR NEW YORK NY 10022 650-843-5000
Valence CDK SPV, L.P. (Reporting) CIK: 0001600038 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 151141895